Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/26438
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLim, Wei Ling Florence-
dc.contributor.authorHuynh, Kevin-
dc.contributor.authorChatterjee, Pratishtha-
dc.contributor.authorMartins, Ian-
dc.contributor.authorJayawardana, Kaushala S-
dc.contributor.authorGiles, Corey-
dc.contributor.authorMellett, Natalie A-
dc.contributor.authorLaws, Simon M-
dc.contributor.authorBush, Ashley I-
dc.contributor.authorRowe, Christopher C-
dc.contributor.authorVillemagne, Victor L-
dc.contributor.authorAmes, David-
dc.contributor.authorDrew, Brian G-
dc.contributor.authorMasters, Colin L-
dc.contributor.authorMeikle, Peter J-
dc.contributor.authorMartins, Ralph N-
dc.date.accessioned2021-05-10T07:13:30Z-
dc.date.available2021-05-10T07:13:30Z-
dc.date.issued2020-
dc.identifier.citationJournal of Alzheimer's Disease : JAD 2020; 76(1): 303-315en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/26438-
dc.description.abstractLipid metabolism is altered in Alzheimer's disease (AD); however, the relationship between AD risk factors (age, APOEɛ4, and gender) and lipid metabolism is not well defined. We investigated whether altered lipid metabolism associated with increased age, gender, and APOE status may contribute to the development of AD by examining these risk factors in healthy controls and also clinically diagnosed AD individuals. We performed plasma lipidomic profiling (582 lipid species) of the Australian Imaging, Biomarkers and Lifestyle flagship study of aging cohort (AIBL) using liquid chromatography-mass spectrometry. Linear regression and interaction analysis were used to explore the relationship between risk factors and plasma lipid species. We observed strong associations between plasma lipid species with gender and increasing age in cognitively normal individuals. However, APOEɛ4 was relatively weakly associated with plasma lipid species. Interaction analysis identified differential associations of sphingolipids and polyunsaturated fatty acid esterified lipid species with AD based on age and gender, respectively. These data indicate that the risk associated with age, gender, and APOEɛ4 may, in part, be mediated by changes in lipid metabolism. This study extends our existing knowledge of the relationship between the lipidome and AD and highlights the complexity of the relationships between lipid metabolism and AD at different ages and between men and women. This has important implications for how we assess AD risk and also for potential therapeutic strategies involving modulation of lipid metabolic pathways.en
dc.language.isoeng
dc.subjectAPOEɛ4en
dc.subjectAgingen
dc.subjectAlzheimer’s diseaseen
dc.subjectgenderen
dc.subjectlipid speciesen
dc.titleRelationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer's Disease.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of Alzheimer's Disease : JADen
dc.identifier.affiliationNational Ageing Research Institute, Parkville, Victoria, VIC, Australiaen
dc.identifier.affiliationSchool of Psychiatry and Clinical Neurosciences, The University of Western Australia, Perth, WA, Australiaen
dc.identifier.affiliationAustralian Alzheimer's Research Foundation, Nedlands, Western Australia, WA, Australiaen
dc.identifier.affiliationBaker Heart and Diabetes Institute, Melbourne, Victoria, VIC, Australiaen
dc.identifier.affiliationSchool of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, WA, Australiaen
dc.identifier.affiliationCooperative Research Centre (CRC) for Mental Health, Australiaen
dc.identifier.affiliationMonash University, Melbourne, Victoria, VIC, Australiaen
dc.identifier.affiliationDepartment of Biomedical Sciences, Macquarie University, North Ryde, New South Wales, NSW, Australiaen
dc.identifier.affiliationKaRa Institute of Neurological Disease, Sydney, Macquarie Park, New South Wales, NSW, Australiaen
dc.identifier.affiliationCollaborative Genomics Group, School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, WA, Australiaen
dc.identifier.affiliationSchool of Pharmacy and Biomedical Sciences, Faculty of Health Sciences, Curtin Health Innovation Research Institute, Curtin University, Western Australia, WA, Australiaen
dc.identifier.affiliationThe Florey Department of Neuroscience and Mental Health, The University of Melbourne, Victoria, VIC, Australiaen
dc.identifier.affiliationMolecular Imaging and Therapyen
dc.identifier.affiliationMedicine (University of Melbourne)en
dc.identifier.doi10.3233/JAD-191304en
dc.type.contentTexten
dc.identifier.pubmedid32474467
local.name.researcherMasters, Colin L
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

54
checked on Dec 22, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.